eVeDrug
Created in 2013
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,992 583Activities
Technologies
Entity types
Location
6 Rue du Maréchal Leclerc, 91270 Vigneux-sur-Seine, France
Vigneux-sur-Seine
France
Employees
Scale: 2-10
Estimated: 6
Engaged corporates
12
2 5Added in Motherbase
5 years, 6 months ago
biotech Value proposition
[Automatic translation follows] eVeDrug calls on different stakeholders all linked to the field of Pharmacovigilance: professionals from the pharmaceutical industry and scientists who have pooled their know-how, and with their experience acquired both from industrial environments (laboratories and manufacturers ) as well as Institutional environments (health authorities in different countries).
eVeDrug wishes above all to restore trust between patients and their health system by placing the main interested party (the patient themselves) at the center of the health system responsible for protecting them.
Thus, eVeDrug distributes the free My eReport application which allows any person (patient, relative, health professional, etc.) who has taken a medication or any other health product, and presents an adverse effect likely to be due to this medicine or this other health product, to declare it directly from your Smartphone or any other mobile terminal (tablet, etc.).
My eReport includes all the minimum information necessary to transmit a case: a declarant; a patient ; a medicine and the description of the adverse effect.
Your declaration will be sent as a priority to the pharmaceutical laboratory concerned, if it is a subscriber to eVeDrug.
Otherwise, your report will be sent to the National Agency of the country in which the adverse effect occurred. In France, your declaration will be sent to one of the Regional Pharmacovigilance Centers dependent on the National Agency for the Safety of Medicines and Health Products (ANSM).
In order to keep track of your declaration and be able to consult it at any time, a duplicate of your declaration is kept on your Smartphone (or on your tablet, etc.).
eVeDrug also distributes My eClinical intended for any investigator wishing to report an SAE to the sponsor directly from their Smartphone (or any other digital medium).
Post Market Declarations: My eReport, Pre Market Declarations: My eClinical, Monitoring of sensitive drugs (inverted black triangle), and Monitoring of PASS / PAES studiesOriginal language
eVeDrug fait appel à différents intervenants tous liés au domaine de la Pharmacovigilance : des professionnels de l'industrie pharmaceutiques et des scientifiques ayant mis leur savoir faire en commun, et forts de leur expérience acquise aussi bien auprès des milieux Industriels (les laboratoires et les fabricants) que des milieux Institutionnels (les autorités de santé de différents pays).
eVeDrug souhaite avant tout restaurer la confiance entre les patients et leur système de santé en plaçant le principal intéressé (le patient lui-même) au centre du système de santé chargé le protéger.
Ainsi, eVeDrug distribue l'application gratuite My eReport qui permet à toute personne (patient, proche, professionnel de santé ...) qui a pris un médicament ou tout autre produit de santé, et présentant un effet indésirable susceptible d'être dû à ce médicament ou à cet autre produit de santé, de le déclarer directement à partir de son Smartphone ou de tout autre terminal mobile (tablette...).
My eReport comprend toutes les informations minimales nécessaires à la transmission d'un cas : un déclarant ; un patient ; un médicament et la description de l'effet indésirable.
Votre déclaration sera transmise en priorité au laboratoire pharmaceutique concerné, si celui-ci est abonné à eVeDrug.
A défaut, votre déclaration sera transmise à l'Agence Nationale du pays dans lequel l'effet indésirable est survenu. En France, votre déclaration sera transmise à l'un des Centres Régionaux de Pharmacovigilance dépendant de l'Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM).
Afin de garder trace de votre déclaration et de pouvoir la consulter à tout moment, un double de votre déclaration est conservé sur votre Smartphone (ou sur votre tablette ...).
eVeDrug distribue également My eClinical destinée à tout investigateur souhaitant déclarer au promoteur un EIG directement depuis son Smartphone (ou tout autre support numérique).
Déclarations Post Market : My eReport, Déclarations Pré Market : My eClinical, Suivi de médicaments sensibles (triangle noir inversé), and Suivi des études PASS / PAES
eVeDrug - Solutions of health vigilances and e-health
https://www.evedrug.eu/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Other 31 Mar 2023 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 30 Jan 2021 | | |
 Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 23 Mar 2016 | | |
 Huawei Electricals, Telecommunications | Huawei Electricals, Telecommunications | Other 6 Mar 2020 | | |
 Assurance Maladie Insurance, Government Administration | Assurance Maladie Insurance, Government Administration | Other 26 Sep 2016 | | |
 Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Institut du Cerveau – Paris Brain Institute Startup accelerator & VC, Biotechnology Research | Not capitalistic Partnership Event 30 Oct 2019 | | |
 Orange Services Pharmaceutical, IT Services and IT Consulting | Orange Services Pharmaceutical, IT Services and IT Consulting | Other 17 Dec 2020 | | |
 Keyrus IT services, IT Services and IT Consulting | Keyrus IT services, IT Services and IT Consulting | Other 3 Mar 2020 | | |
 HUB-TDAY Insurance Insurance | HUB-TDAY Insurance Insurance | Other 8 Jun 2017 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 24 Feb 2020 | | |